Sonnet BioTherapeutics Azioni (NASDAQ: SONN)

Ultime notizie per Sonnet BioTherapeutics (NASDAQ:SONN) Azioni

Sonnet BioTherapeutics

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics Holdings Inc

Enliven Therapeutics, Inc. (Enliven or the Company) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVN#NASDAQ">ELVN</a>), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that it has priced its previously announced underwritten public offering of 8,394,737 shares of its common stock at a price to the public of $19.66 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase up to 1,780,263 shares of Enliven's common stock at a price to the public of $19.659 per pre-funded warrant, which represents the per share public offering price of each share of Enliven's common stock less the $0.001 per share exercise price for each pre-funded warrant. All of the shares and pre-funded warrants are being sold by Enliven.&nbsp;
The gross proceeds from the offering are expected to be approximately $200 million before deducting underwriting discounts and commissions and other offering expenses.&nbsp;The offering is expected to close on or about June 16, 2025, subject to satisfaction of customary closing conditions. In addition, Enliven has granted the underwriters a 30-day option to purchase up to an additional 1,526,250 shares of its common stock at the public offering price, less the underwriting discounts and commissions.

News

Offerings

ELVN

Enliven Therapeutics Prices Underwritten Public Offering Of 8.39M Shares At $19.66/Shr

Barrington Research analyst Vincent Colicchio maintains Alithya Group (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ALYA#TSX">ALYA</a>) with a Outperform and raises the price target from C$2.5 to C$3.

Price Target

Analyst Ratings

TSX:ALYA

Barrington Research Maintains Outperform on Alithya Group, Raises Price Target to C$3

Senmiao Technology Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIHS#NASDAQ">AIHS</a>) on Friday announced a <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/g45922822/senmiao-technology-signs-a-strategic-cooperation-agreement-with-changsha-yipeng-to-develop-an-ai-b" rel="noreferrer noopener">strategic partnership</a> with Changsha Yipeng Information Technology Co., Ltd. to develop an AI-backed data management system to improve efficiency of online ride-hailing management platforms.
The system will leverage Senmiao&#8217;s historical data on drivers, vehicles, and riders to improve fleet efficiency and service safety. Changsha Yipeng, with over a decade of experience in AI and data systems, will lead the platform&#8217;s development.
The two companies will also pursue joint funding to support the project&#8217;s rollout.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/tech/25/06/45749260/weride-renault-bring-autonomous-shuttles-back-to-roland-garros-in-paris" rel="noreferrer noopener">WeRide, Renault Bring Autonomous Shuttles Back To Roland-Garros In Paris</a>
&#8220;Following the recent sale of our ride-hailing platform, we&#8217;ve been looking for new ways to monetize our large data assets,&#8221; said Xi Wen, Chairman and CEO of Senmiao. &#8220;This partnership helps us unlock that value through advanced AI capabilities.&#8221;
With this move, Senmiao is shifting toward becoming a tech enabler for mobility service providers, focusing on data-driven solutions rather than platform operations.
On Thursday, Senmiao Technology <a href="https://www.benzinga.com/pressreleases/25/06/g45901107/senmiao-technology-and-qinhong-international-group-sign-a-strategic-cooperation-agreement-to-joint" target="_blank" rel="noreferrer noopener">signed</a> a strategic agreement with Qinhong International Group to expand its presence across China and access new financing channels.
The partnership aims to leverage shared customer networks and financial relationships to support growth and increase revenue opportunities for both companies.
Related ETFs: Global X Autonomous &amp; Electric Vehicles ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRIV#NASDAQ">DRIV</a>), First Trust Nasdaq Artificial Intelligence ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROBT#NASDAQ">ROBT</a>).
Price Action: AIHS shares are trading lower by 43.72% to $0.58 premarket at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45921026/chinese-antitrust-regulator-delays-35-billion-us-chip-merger-amid-trade-tensions-report" target="_blank" rel="noreferrer noopener">Chinese Antitrust Regulator Delays $35 Billion US Chip Merger Amid Trade Tensions: Report</a></li>
</ul>
Image via Shutterstock

Asia

Movers

Tech

AIHS

DRIV

ROBT

Senmiao Technology Signs AI Deal To Leverage Historical Ride-Hailing Data

Ripple CEO Brad Garlinghouse believes (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>) could take on a significant slice of the cross-border payments market, potentially facilitating 14% of the volume currently routed through SWIFT within the next five years. 
Speaking at the XRP APEX 2025 event in Singapore, Garlinghouse emphasized XRP's capacity to streamline global liquidity rather than just replace messaging infrastructure, Coindesk <a href="https://www.coindesk.com/markets/2025/06/13/xrp-could-capture-14-of-swifts-global-volume-ripple-ceo-says">reported</a>.
"SWIFT today is made up of two functions: messaging and liquidity," Garlinghouse explained. "Liquidity is managed by banks. I'm less concerned about messaging and more focused on the liquidity side. If you're facilitating liquidity, it benefits XRP." 
Based on this thesis, he suggested XRP could power 14% of SWIFT's existing transaction volume by 2030.
While SWIFT remains the dominant infrastructure for interbank cross-border messaging, it doesn't actually transfer money. 
Transactions initiated through SWIFT often pass through multiple intermediaries, resulting in slower settlement times and higher costs. 
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45912870/gamestops-bitcoin-strategy-draws-skepticism-amid-1-75b-debt-offering">GameStop&#8217;s Bitcoin Strategy Draws Skepticism Amid $1.75B Debt Offering</a>
Ripple is positioning itself as an alternative by targeting the liquidity layer, where capital is physically moved, rather than merely improving communications between financial institutions.
Ripple's system enables both the transmission of transactional data and the movement of funds using blockchain. 
XRP functions as a bridge asset, allowing one currency to be instantly converted into another, which eliminates the need for banks to maintain foreign reserve accounts.
This model could reduce friction and costs associated with traditional correspondent banking and offer a faster, more efficient alternative for international money transfers.
Read Next: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45910391/over-30-of-bitcoin-supply-controlled-by-centralized-entities-report">Over 30% Of Bitcoin Supply Controlled By Centralized Entities: Report</a>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$XRP

Ripple CEO Projects XRP Could Handle 14% Of SWIFT's Cross-Border Payment Volume Within Five Years

Wells Fargo analyst Michael Turrin maintains Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) with a Overweight and raises the price target from $430 to $470.

ADBE

Wells Fargo Maintains Overweight on Adobe, Raises Price Target to $470

<a href="https://www.wsj.com/livecoverage/israel-iran-strike-conflict/card/trump-to-wsj-u-s-was-aware-of-israel-s-plans-to-attack-iran-4613AzRhb9WHfBFytL8Y?mod=e2tw" title="https://www.wsj.com/livecoverage/israel-iran-strike-conflict/card/trump-to-wsj-u-s-was-aware-of-israel-s-plans-to-attack-iran-4613AzRhb9WHfBFytL8Y?mod=e2tw">https://www.wsj.com/livecoverage/israel-iran-strike-conflict/card/trump-to-wsj-u-s-was-aware-of-israel-s-plans-to-attack-iran-4613AzRhb9WHfBFytL8Y?mod=e2tw</a>

Macro Economic Events

Politics

Global

Economics

General

President Trump Tells WSJ US Was Aware Of Israel's Plans To Attack Iran

Wells Fargo analyst Zachary Fadem maintains RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) with a Overweight and raises the price target from $250 to $275.

Wells Fargo Maintains Overweight on RH, Raises Price Target to $275

Wells Fargo analyst Chris Carey maintains Monster Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NASDAQ">MNST</a>) with a Overweight and raises the price target from $67 to $70.

MNST

Wells Fargo Maintains Overweight on Monster Beverage, Raises Price Target to $70

BMO Capital analyst Keith Bachman reiterates Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) with a Outperform and maintains $450 price target.

Reiteration

BMO Capital Reiterates Outperform on Adobe, Maintains $450 Price Target

WIIM

ODDITY Tech shares are trading lower after the company announced the pricing of a $525 million offering.

Wells Fargo analyst Michael Berg maintains Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) with a Overweight and raises the price target from $335 to $365.

MNDY

Wells Fargo Maintains Overweight on Monday.Com, Raises Price Target to $365

NextDecade shares are trading higher after the company announced it finalized its EPC Contract Refresh for Train 4 and Executes EPC Contract for Train 5 at the Rio Grande.

BMO Capital analyst Keith Bachman upgrades Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) from Market Perform to Outperform and raises the price target from $200 to $235.

Upgrades

ORCL

BMO Capital Upgrades Oracle to Outperform, Raises Price Target to $235

Wells Fargo analyst Michael Turrin maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Overweight and raises the price target from $225 to $250.

SNOW

Wells Fargo Maintains Overweight on Snowflake, Raises Price Target to $250

Wells Fargo analyst Michael Turrin maintains Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) with a Overweight and raises the price target from $515 to $565.

MSFT

Wells Fargo Maintains Overweight on Microsoft, Raises Price Target to $565

Wells Fargo analyst Michael Turrin maintains Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) with a Overweight and raises the price target from $825 to $880.

INTU

Wells Fargo Maintains Overweight on Intuit, Raises Price Target to $880

UBS analyst Joseph Spak maintains Dana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAN#NYSE">DAN</a>) with a Buy and raises the price target from $20 to $22.

UBS Maintains Buy on Dana, Raises Price Target to $22

Lennar Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) will release earnings results for the second quarter, after the <a href="https://www.benzinga.com/quote/LEN/earnings">closing bell on Monday, June 16.</a>
Analysts expect the Miami, Florida-based company to report quarterly earnings at $1.94 per share, down from $3.38 per share in the year-ago period. Lennar projects to report quarterly revenue at $8.19 billion, compared to $8.77 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On April 9, the company's board declared a quarterly cash dividend of 50 cents per share for both Class A and Class B common stock.
Lennar shares gained 0.6% to close at $112.15 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/LEN/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Wells Fargo analyst Deepa Raghavan maintained an Equal-Weight rating and cut the price target from $120 to $110 on April 9, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintained a Market Perform rating and cut the price target from $141 to $128 on March 25, 2025. This analyst has an accuracy rate of 67%.</li>
<li>UBS analyst John Lovallo maintained a Buy rating and cut the price target from $183 to $164 on March 24, 2025. This analyst has an accuracy rate of 65%.</li>
<li>RBC Capital analyst Mike Dahl maintained a Sector Perform rating and slashed the price target from $125 to $122 on March 24, 2025. This analyst has an accuracy rate of 73%.</li>
<li>Barclays analyst Matthew Bouley maintained an Equal-Weight rating and cut the price target from $121 to $110 on March 24, 2025. This analyst has an accuracy rate of 72%.</li>
</ul>
Considering buying LEN stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/LEN/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="561" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12222313/image-204-1024x561.png" alt="" class="wp-image-948365" style="width:613px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12222313/image-204-1024x561.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12222313/image-204-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12222313/image-204-768x421.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/12222313/image-204.png 1145w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45902941/top-2-defensive-stocks-that-may-keep-you-up-at-night-in-q2">Top 2 Defensive Stocks That May Keep You Up At Night In Q2</a> </li>
</ul>
Photo via Shutterstock

Earnings

Markets

Trading Ideas

Lennar Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) slipped amid heightened <a href="https://www.benzinga.com/markets/market-summary/25/06/45918802/middle-east-tensions-rattle-markets-us-stock-futures-slide-oil-jumps-8-gold-surges-above-3400-after-israel-strikes-iran">geopolitical tensions</a> following Israel&#8217;s attack on Iran. Traders questioned whether this signals a full-on crash or a temporary reaction.
What Happened: In an X post on June 13, crypto trader Jackis jokingly called Bitcoin's drop a trip to "Goblin Town"—or if markets are overreacting to fear-inducing headlines. Jackis noted that while the situation is alarming, similar Middle East conflicts have triggered emotional but short-lived market dips in the past. He said this may be another instance of fear-driven selling rather than a genuine breakdown of fundamentals.
Jackis <a href="https://x.com/i_am_jackis/status/1933433496489353649">emphasized</a> that Bitcoin remains in a macro bullish structure, consolidating inside a vertical ascending channel for over 200 days. This consolidation is seen as a re-accumulation phase that typically precedes major breakouts.
<ul class="wp-block-list">
<li>The pullback from May 22 to June 5 ended with a bullish daily structure break and if BTC holds the $100,400 low, the move is likely just a retest.</li>
<li>A massive $1.14 billion liquidation event, the largest since February, may have flushed out weak hands, potentially marking a local bottom, as it did earlier this year.</li>
<li>New liquidity zones have now formed around $111,000.</li>
</ul>
He said the drop is more about fear than fundamentals, highlighting Bitcoin's rising demand and solid on-chain metrics.
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45902384/ethereum-etfs-outpace-bitcoin-etfs-with-240m-inflows-on-june-11">Ethereum ETFs Outpace Bitcoin ETFs With $240M Inflows On June 11</a>
What's Next: Jackis advised traders to watch the weekly close for confirmation. If BTC maintains its recent low, an upside continuation is expected. However, if it breaks lower, the next strong support lies at $93,000—though the macrostructure remains intact even in that scenario.
Crypto trader Xremlin <a href="https://x.com/0x_gremlin/status/1933468506365816863">offered</a> a different take, arguing that war has historically been bullish for Bitcoin:
<ul class="wp-block-list">
<li>In April 2024, following Iran&#8217;s attack on Israel, BTC rose 18% in two weeks and 28% over 1.5 months.</li>
</ul>
<ul class="wp-block-list">
<li>In October 2024, Bitcoin surged 10% in the first week after renewed conflict and 62% over the following two months after Israel struck back.</li>
</ul>
Now, in June 2025, Bitcoin has dropped 2.5% in response to similar news. Xremlin remains curious: Will the historical pattern repeat?
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45837005/strategy-buys-another-110-million-in-bitcoin-now-holds-582000-btc">Strategy Buys Another $110 Million In Bitcoin, Now Holds 582,000 BTC</a></li>
</ul>
Photo: Shutterstock

$BTC

Will Bitcoin Crash To 'Goblin Town' Or Is This Just A Geopolitical Overreaction?

UBS analyst Leonardo Olmos maintains Vtex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTEX#NYSE">VTEX</a>) with a Buy and lowers the price target from $11 to $10.

VTEX

UBS Maintains Buy on Vtex, Lowers Price Target to $10

Health Care

Press Releases

Sonnet BioTherapeutics Presents Compilation of Data Highlighting the Potential of SON-1010 as a Monotherapy or a Combination Therapy to Improve the Treatment of Solid Tumors

Sonnet BioTherapeutics Holdings, Inc. Participates in the Virtual Investor "Top 5 for '25" On-Demand Conference

Virtual Investor Releases Next Wave of "Top 5 for '25" On-Demand Videos

Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter of Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant Protein

Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas

Management

Sonnet Announces the Passing of Founder and CEO Pankaj Mohan, Ph.D.

Sonnet Announces Release of Corporate Update Video

Sonnet's SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose

Comments

Sonnet BioTherapeutics

Notizie

Ultime notizie per Sonnet BioTherapeutics (NASDAQ:SONN) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO